FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W131390778> ?p ?o ?g. }

• W131390778 endingPage "441" @default.
• W131390778 startingPage "432" @default.
• W131390778 abstract "This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.The SXscore can identify patients treated with PCI who are at highest risk of adverse events.The SXscore was calculated prospectively in 2,033 of the 2,292 patients enrolled in the RESOLUTE All Comers study (RESOLUTE III All Comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). Clinical outcomes in terms of a patient-oriented composite endpoint (POCE) of all-cause death, myocardial infarction (MI), and repeat revascularization; the individual components of POCE; target lesion failure (TLF) (a composite of cardiac death, target-vessel MI, and clinically driven target lesion revascularization); and stent thrombosis were subsequently stratified according to SXscore tertiles: SXscore(LOW) ≤ 9 (n = 698), 9 <SXscore(MID) ≤ 17 (n = 676); SXscore(HIGH) >17 (n = 659).At 12-month follow-up, rates of POCE, MI, repeat revascularization, TLF, and the composite of death/MI were all significantly higher in patients in the highest SXscore tercile. Rates of stent thrombosis were all highest in the SXscore(HIGH) tertile (p > 0.05). After multivariate adjustment, the SXscore was identified as an independent predictor of POCE, MI, repeat revascularization, and TLF (p < 0.05 for all). At 12-month follow-up, the SXscore, ACEF score, and Clinical SXscore had C-statistics of 0.57, 0.78, and 0.67, respectively, for mortality and of 0.62, 0.56, 0.63, respectively, for POCE. No significant between-stent differences were observed for TLF or POCE in any of the SXscore tertiles.The SYNTAX score is able to stratify risk amongst an all-comers population treated with PCI with second-generation drug-eluting stents (DES); however, improvements can be made with the inclusion of clinical variables. (RESOLUTE III All Comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention; NCT00617084)." @default.
• W131390778 created "2016-06-24" @default.
• W131390778 creator A5000945456 @default.
• W131390778 creator A5012791093 @default.
• W131390778 creator A5015188296 @default.
• W131390778 creator A5022649152 @default.
• W131390778 creator A5026908997 @default.
• W131390778 creator A5029191375 @default.
• W131390778 creator A5033359462 @default.
• W131390778 creator A5039789130 @default.
• W131390778 creator A5040186735 @default.
• W131390778 creator A5041502706 @default.
• W131390778 creator A5043220112 @default.
• W131390778 creator A5045977148 @default.
• W131390778 creator A5048845661 @default.
• W131390778 creator A5052135413 @default.
• W131390778 creator A5053194091 @default.
• W131390778 creator A5057534153 @default.
• W131390778 creator A5058149870 @default.
• W131390778 creator A5059617202 @default.
• W131390778 creator A5063792624 @default.
• W131390778 creator A5068286741 @default.
• W131390778 creator A5068413010 @default.
• W131390778 creator A5080770746 @default.
• W131390778 creator A5083493788 @default.
• W131390778 date "2011-04-01" @default.
• W131390778 modified "2023-10-01" @default.
• W131390778 title "The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents" @default.
• W131390778 cites W131751662 @default.
• W131390778 cites W1610499235 @default.
• W131390778 cites W1795635013 @default.
• W131390778 cites W1921048136 @default.
• W131390778 cites W1975818117 @default.
• W131390778 cites W1982463626 @default.
• W131390778 cites W1984355866 @default.
• W131390778 cites W2009589924 @default.
• W131390778 cites W2026583578 @default.
• W131390778 cites W2028978425 @default.
• W131390778 cites W2031917264 @default.
• W131390778 cites W2052352704 @default.
• W131390778 cites W2085477178 @default.
• W131390778 cites W2087150869 @default.
• W131390778 cites W2098931866 @default.
• W131390778 cites W2116342186 @default.
• W131390778 cites W2121668181 @default.
• W131390778 cites W2125716797 @default.
• W131390778 cites W2140991303 @default.
• W131390778 cites W2141686284 @default.
• W131390778 cites W2144552468 @default.
• W131390778 cites W2149256184 @default.
• W131390778 cites W2149421477 @default.
• W131390778 doi "https://doi.org/10.1016/j.jcin.2011.01.008" @default.
• W131390778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21511223" @default.
• W131390778 hasPublicationYear "2011" @default.
• W131390778 type Work @default.
• W131390778 sameAs 131390778 @default.
• W131390778 citedByCount "95" @default.
• W131390778 countsByYear W1313907782012 @default.
• W131390778 countsByYear W1313907782013 @default.
• W131390778 countsByYear W1313907782014 @default.
• W131390778 countsByYear W1313907782015 @default.
• W131390778 countsByYear W1313907782016 @default.
• W131390778 countsByYear W1313907782017 @default.
• W131390778 countsByYear W1313907782018 @default.
• W131390778 countsByYear W1313907782019 @default.
• W131390778 countsByYear W1313907782020 @default.
• W131390778 countsByYear W1313907782021 @default.
• W131390778 countsByYear W1313907782022 @default.
• W131390778 countsByYear W1313907782023 @default.
• W131390778 crossrefType "journal-article" @default.
• W131390778 hasAuthorship W131390778A5000945456 @default.
• W131390778 hasAuthorship W131390778A5012791093 @default.
• W131390778 hasAuthorship W131390778A5015188296 @default.
• W131390778 hasAuthorship W131390778A5022649152 @default.
• W131390778 hasAuthorship W131390778A5026908997 @default.
• W131390778 hasAuthorship W131390778A5029191375 @default.
• W131390778 hasAuthorship W131390778A5033359462 @default.
• W131390778 hasAuthorship W131390778A5039789130 @default.
• W131390778 hasAuthorship W131390778A5040186735 @default.
• W131390778 hasAuthorship W131390778A5041502706 @default.
• W131390778 hasAuthorship W131390778A5043220112 @default.
• W131390778 hasAuthorship W131390778A5045977148 @default.
• W131390778 hasAuthorship W131390778A5048845661 @default.
• W131390778 hasAuthorship W131390778A5052135413 @default.
• W131390778 hasAuthorship W131390778A5053194091 @default.
• W131390778 hasAuthorship W131390778A5057534153 @default.
• W131390778 hasAuthorship W131390778A5058149870 @default.
• W131390778 hasAuthorship W131390778A5059617202 @default.
• W131390778 hasAuthorship W131390778A5063792624 @default.
• W131390778 hasAuthorship W131390778A5068286741 @default.
• W131390778 hasAuthorship W131390778A5068413010 @default.
• W131390778 hasAuthorship W131390778A5080770746 @default.
• W131390778 hasAuthorship W131390778A5083493788 @default.
• W131390778 hasBestOaLocation W1313907781 @default.
• W131390778 hasConcept C126322002 @default.
• W131390778 hasConcept C164705383 @default.
• W131390778 hasConcept C168563851 @default.
• W131390778 hasConcept C203092338 @default.

• next